Tobacco use, primarily through cigarette smoking, is responsible for about 5 million deaths annually, making it the largest cause of preventable mortality in the world, and nicotine is the component in tobacco that is responsible for the maintenance of smoking. This project builds upon the foundation laid in the first 5-year funding period of the Collaborative Genetic Study of Nicotine Dependence. We have identified several genes that affect susceptibility for nicotine dependence, such as the alphas nicotinic receptor, GABA4 genes. While identification of these genes represents significant progress toward our goal of understanding the molecular basis of nicotine dependence, many questions remain. The overarching goal of this project is to understand how these genes affect the susceptibility to develop nicotine dependence and related phenotypes, including alcohol and drug dependence, major depressive disorder and anxiety disorders. We are approaching this goal from several directions: expanded examination of nicotine dependence and related phenotypes, innovative genetic analyses, and incorporation of endophenotypic measurement of nicotine metabolism, which was performed on a subset of subjects. These goals will be accomplished through the integration and analysis of the extensive phenotypic, genetic, and endophenotypic data previously collected.
Aim 1 : To expand the genetic epidemiologic and association studies to examine different definitions of nicotine dependence, correlated phenotypes of alcohol dependence, major depressive disorder, anxiety disorder and other comorbidities. Correlated quantitative phenotypes will also be examined.
Aim 2 : To further investigate and model the complex genetic structure underlying risk for nicotine dependence. This work will include development and application of methods for genetic analysis of genegene and gene-environment interactions, using tools such as logistic regression, artificial neural networks (ANNs), and methods that account for the evolutionary history of the loci and haplotypes being analyzed.
Aim 3 : To incorporate and extend the endophenotypic measurement of nicotine metabolism into genetic analyses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA089392-07
Application #
7874633
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
7
Fiscal Year
2009
Total Cost
$515,419
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Wang, Kesheng; Chen, Xue; Ward, Stephen C et al. (2018) CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. Int J Obes (Lond) :
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Chiu, Ami; Hartz, Sarah; Smock, Nina et al. (2018) Most Current Smokers Desire Genetic Susceptibility Testing and Genetically-Efficacious Medication. J Neuroimmune Pharmacol 13:430-437
Culverhouse, R C; Saccone, N L; Horton, A C et al. (2018) Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry 23:133-142
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Liu, Dungang; Zhang, Heping (2018) Residuals and Diagnostics for Ordinal Regression Models: A Surrogate Approach. J Am Stat Assoc 113:845-854
Glasheen, Cristie; Johnson, Eric O; Saccone, Nancy L et al. (2018) Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence. Drug Alcohol Depend 185:127-132
Teitelbaum, A M; Murphy, S E; Akk, G et al. (2018) Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. Pharmacogenomics J 18:136-143
Hancock, D B; Guo, Y; Reginsson, G W et al. (2018) Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence. Mol Psychiatry 23:1-9
Cabana-Domínguez, Judit; Arenas, Concepció; Cormand, Bru et al. (2018) MiR-9, miR-153 and miR-124 are down-regulated by acute exposure to cocaine in a dopaminergic cell model and may contribute to cocaine dependence. Transl Psychiatry 8:173

Showing the most recent 10 out of 268 publications